<DOC>
	<DOCNO>NCT02398240</DOCNO>
	<brief_summary>The addition Brentuximab vedotin ( Bv ) combination chemotherapy safe , well tolerate effective child , adolescent young adult stag newly diagnose Hodgkin lymphoma ( HL ) .</brief_summary>
	<brief_title>Brentuximab Newly Diagnosed Hodgkin Disease</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Normal Serum creatinine base age creatinine clearance &gt; 60 ml/min/1.73 m2 equivalent radioisotope glomerular filtration rate ( GFR ) determine institutional normal range . Direct bilirubin &lt; 1.5 upper limit normal ( ULN ) age , SGOT ( AST ) SGPT ( ALT ) &lt; 3 x ULN Shortening fraction &gt; 27 % echocardiogram , Ejection fraction &gt; 50 % radionuclide angiogram echocardiogram . For patient age 116 year , Lansky score ≥60 . For patient &gt; 16 year , Karnofsky score ≥60 . No prior Hodgkin lymphoma direct therapy allow except emergent mediastinal irradiation ( &lt; 1000cGy ) superior vena cava ( SVC ) syndrome . Females pregnant ( positive HCG ) lactating . Karnofsky &lt; 60 % Lansky &lt; 60 % less 16 year age . Age ≤1 year &gt; 29.99 year age .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>